References
- Chang CK, Jacobs IA, Salti GI: Outcomes of surgery for dermatofibrosarcoma protuberans. Eur J Surg Oncol 30: 341, 2004 https://doi.org/10.1016/j.ejso.2003.12.005
- Monnier D, Vidal C, Martin L, Danzon A, Pelletier F, Puzenat E, Algros MP, Blanc D, Laurent R, Humbert PH, Aubin F: Dermatofibrosarcoma protuberans: a population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002. J Eur Acad Dermatol Venereol 20: 1237, 2006 https://doi.org/10.1111/j.1468-3083.2006.01780.x
- Dader J, Ferrand M: Dermatofibromes progressives et recidivants ou fibrosarcomes de la peau. Ann Dermatol Syphiligr 5: 545, 1924
- Hoffman E: Ueber alas knollentribende fibrosarkam der haut (dermatofibrosarcoma protuberans). Dermatol Z 43: 1, 1925 https://doi.org/10.1159/000250699
- Sandberg AA, Bridge JA: Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. dermatofibrosarcoma protuberans and giant cell fibroblastoma. Cancer Genet Cytogenet 140: 1, 2003 https://doi.org/10.1016/S0165-4608(02)00848-8
- Shimizu A, OBrien KP, Sjoblom T, Pietras K, Buchdunger E, Collins VP, Heldin CH, Dumanski JP, Ostman A: The dermatofibrosarcoma protuberans-associated collagen type lalpha1/platelet-derived growth factor (PDGF) B-chain fusion gene generates a transforming protein that is processed to functional PDGFBB. Cancer Res 59: 3719, 1999
- Aiba S, Tabata N, Ishii H, Ootani H, Tagami H: Dermatofibrosarcoma protuberans is a unique fibrohistiocytic tumour expressing CD34. Br J Dermatol 127: 79, 1992 https://doi.org/10.1111/j.1365-2133.1992.tb08036.x
- Wood L, Fountaine TJ, Rosamilia L, Helm KF, Clarke LE: Cutaneous CD34+ spindle cell neoplasms: histopathologic features distinguish spindle cell lipoma, solitary fibrous tumor, and dermatofibrosarcoma protuberans. Am J Dermatopathol 32: 764, 2010 https://doi.org/10.1097/DAD.0b013e3181d0c587
- Lemm D, Mugge LO, Mentzel T, Hoffken K: Current treatment options in dermatofibrosarcoma protuberans. J Cancer Res Clin Oncol 135: 653, 2009 https://doi.org/10.1007/s00432-009-0550-3
- Mendenhall WM, Zlotecki RA, Scarborough MT: Dermatofibrosarcoma protuberans. Cancer 101: 2503, 2004 https://doi.org/10.1002/cncr.20678
- Gloster HM Jr: Dermatofibrosarcoma protuberans. J Am Acad Dermatol 35: 355, 1996 https://doi.org/10.1016/S0190-9622(96)90597-6
- Dagan R, Morris CG, Zlotecki RA, Scarborough MT, Mendenhall WM: Radiotherapy in the treatment of dermatofibrosarcoma protuberans. Am J Clin Oncol 28: 537, 2005 https://doi.org/10.1097/01.coc.0000171278.69291.64
- Taylor HB, Helwig EB: Dermatofibrosarcoma protuberans. a study of 115 cases. Cancer 15: 717, 1962 https://doi.org/10.1002/1097-0142(196207/08)15:4<717::AID-CNCR2820150405>3.0.CO;2-2
- Bowne WB, Antonescu CR, Leung DH, Katz SC, Hawkins WG, Woodruff JM, Brennan MF, Lewis JJ: Dermatofibrosarcoma protuberans: a clinicopathologic analysis of patients treated and followed at a single institution. Cancer 88: 2711, 2000 https://doi.org/10.1002/1097-0142(20000615)88:12<2711::AID-CNCR9>3.0.CO;2-M
- Fiore M, Miceli R, Mussi C, Lo Vullo S, Mariani L, Lozza L, Collini P, Olmi P, Casali PG, Gronchi A: Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol 23: 7669, 2005 https://doi.org/10.1200/JCO.2005.02.5122
- Sun LM, Wang CJ, Huang CC, Leung SW, Chen HC, Fang FM, Huang EY, Lee SP: Dermatofibrosarcoma protuberans: treatment results of 35 cases. Radiother Oncol 57: 175, 2000 https://doi.org/10.1016/S0167-8140(00)00228-0
- DuBay D, Cimmino V, Lowe L, Johnson TM, Sondak VK: Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution. Cancer 100: 1008, 2004 https://doi.org/10.1002/cncr.20051
- Fields RC, Hameed M, Qin LX, Moraco N, Jia X, Maki RG, Singer S, Brennan MF: Dermatofibrosarcoma protuberans (DFSP): predictors of recurrence and the use of systemic therapy. Ann Surg Oncol 18: 328, 2011